SCHEMBL6677917

SCHEMBL6677917

CCC/C=C1/C=C(c2cccc(OC)c2)C(CN(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 2/20 0.46
HSP90AA1 P07900 1/20 0.46
SLC6A2 P23975 7/20 0.40
SLC6A4 P31645 7/20 0.40
OPRM1 P35372 6/20 0.40
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
SLC22A1 O15245 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR6 P50406 1/20 0.35
METAP1 P53582 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677920 1.00 CCR6 (0.46) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6678575 0.91 HSP90AA1 (0.47) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6678587 0.91 HSP90AA1 (0.47) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6677864 0.87 HSP90AA1 (0.49) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6677866 0.87 HSP90AA1 (0.49) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL2969421 0.81 HSP90AA1 (0.55) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6718866 0.81 CCR6 (0.48) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6677987 0.81 HSP90AA1 (0.48) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6677991 0.81 CCR6 (0.48) CCR6HSP90AA1SLC6A2SLC6A4OPRM1
SCHEMBL6677339 0.81 HSP90AA1 (0.48) CCR6HSP90AA1SLC6A2SLC6A4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US claimed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US claimed
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP disclosed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 CCR6 1317/4885HSP90AA1 1652/4885SLC6A2 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.